Will COVID-19 be evidence-based medicine's nemesis?

Trisha Greenhalgh

doi:10.1371/journal.pmed.1003266

Will COVID-19 be evidence-based medicine's nemesis?

PLoS Med. 2020 Jun 30;17(6):e1003266. doi: 10.1371/journal.pmed.1003266. eCollection 2020 Jun.

Author

Trisha Greenhalgh¹

Affiliation

¹ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Betacoronavirus
Biomedical Research / trends
COVID-19
Coronavirus Infections*
Evidence-Based Medicine*
Humans
Pandemics*
Pneumonia, Viral*
Randomized Controlled Trials as Topic
SARS-CoV-2

Grants and funding

TG’s research is funded from the following sources: National Institute for Health Research (BRC-1215-20008), UK Research and Innovation (COVID-19 Emergency Fund), and Wellcome Trust (WT104830MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.